Delivery Order SPE2DB22D2108-SPE2DB24FU4SN

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,419.24, is a delivery order for the supply of testosterone cypionate 200 mg/ml injections. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price contract. The award was made on May 29, 2024 and there was no set-aside designation used. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,787.64, is for the supply of testosterone cypionate 200 mg/mL injections. It is a firm fixed-price contract with a completion date of March 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,769.12 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of testosterone cypionate 200 mg/mL medical injections. This order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,447.54 firm fixed-price contract is for the supply of testosterone cypionate 200 mg/mL, with a period of performance through March 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,325.34, is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a fixed-price, firm-fixed-price pricing type and a completion date of January 8, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,193.70, is for the delivery of a testosterone 1% medication product (50 mg/5 g) with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.32 firm fixed-price delivery order contract is for the supply of testosterone cypionate 200 mg/mL, a pharmaceutical product. The contract is not set-aside and has an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 200 mg/mL testosterone cypionate injections. The award has a potential value of $1,196.06 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation and serves as a prime contractor for DLA, providing a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $1,894.21, is for the supply of testosterone 1% (25mg/2.5g) pharmaceutical products. The contract has a completion date of May 15, 2024 and is a firm-fixed-price contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,099.37 firm fixed price contract is for the supply of 4565119542 - Testosterone 1% (50 mg/5 g) medication, with a period of performance through July 12, 2024. The contract was not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4SN
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,356.30 contract is for the supply of testosterone 200 mg/ml injections. The contract has an ultimate completion date of August 20, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a broad range of medical commodities to support military healthcare programs. Amerisourcebergen has also been awarded another notable IDC, valued up to $750,000 through May 2024, with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. The contract does not have a set-aside designation.

Generated 11/18/24, 9:40 AM